Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998

Vaccine

Volumn 20, Issue 1-2, 2001, Pages 7-11

  Van Steenbergen, J E ^a,b   Leentvaar Kuijpers, A ^a   Baayen, D ^a   Dukers, H T M ^a   Van Doornum, G J J ^a   Van Den Hoek, J A R ^a   Coutinho, R A ^a,c  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b National Coordination Communicable Disease Control   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Evaluation; Hepatitis B; Neonatal immunization program

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; GHANA; HEALTH CARE COST; HEPATITIS; HEPATITIS B VIRUS; HUMAN; HUMAN EXPERIMENT; LOW BIRTH WEIGHT; MALE; NETHERLANDS; NEWBORN; NEWBORN CARE; NORMAL HUMAN; PREDICTION; PRENATAL SCREENING; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEROPREVALENCE; SOUTHEAST ASIA; TREATMENT OUTCOME;

ADULT; DISEASE TRANSMISSION, VERTICAL; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT, NEWBORN; MALE; MASS SCREENING; MATERNAL HEALTH SERVICES; NETHERLANDS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; PREVALENCE; PROGRAM EVALUATION;

EID: 0035850995     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00315-2     Document Type: Article

References (30)

1. Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunizing infants of infected mothers in the Netherlands, 1989-1992. National Hepatitis B Steering Committee
2. Screening of pregnant women for hepatitis B
3. Antenatal screening and targeting should be sufficient in some countries
4. Evaluation of the hepatitis B prevention program. II. Amsterdam, 1989-1992
5. Seroprevalence of syphilis, human immunodeficiency virus type-1, and hepatitis B virus infections among pregnant women in Turkey
6. Prévalence des infections par les virus des hépatites A et B au Maroc
7. Hepatitis B markers in Ghanaian pregnant women
8. The epidemiology of hepatitis B infections in a poly-ethnic population
9. Evaluation of the hepatitis B prevention program in neonates. I. Data for the Netherlands, 1990, excluding Amsterdam
10. A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers
11. Maternal hepatitis B screening practices - California, Connecticut, Kansas, and United States, 1992-1993
12. Prevention of perinatal hepatitis B trough enhanced case management - Connecticut, and United States, 1994-1995
13. Program to prevent hepatitis B virus transmission in a health-maintenance organization - Northern California, 1990-1995
14. Hepatitis B maternal screening, infant vaccination, and infant prophylaxis practices in North Carolina
15. Hepatitis B vaccination among children in inner-city public housing, 1991-1997
16. Antenatal screening for carriers of hepatitis B virus. Britain needs a standardised nationwide universal screening programme
17. A neonatal hepatitis B surveillance and vaccination program: New York City, 1987-1988
18. Factors related to maternal compliance with urban perinatal hepatitis B prevention programmes
19. Combined active-passive immunization against the hepatitis B virus: 5 Year follow-up of children born to hepatitis B surface antigen-positive mothers
20. What level of hepatitis B antibody is protective?
21. Hepatitis B vaccination in high-risk infants: 10 Year follow-up
22. Revaccination against hepatitis B virus of non-responding and low-responding infants immunized at birth. A parallel evaluation of rubella and tetanus vaccine
23. Yeast-recombinant hepatitis B vaccine: Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission
24. A 10-year follow-up study of neonatal hepatitis B immunization: Are booster injections indicated?
25. Anti-HBs levels in infants of hepatitis B carrier mothers after delayed active immunization with recombinant vaccine concomitant with DTP-polio vaccine: Is there a need for a second dose of HBIg?
26. A 10-year neonatal hepatitis B vaccination program, the Netherlands, 1982-1992: Protective efficacy and long-term immunogenicity
27. Immunogenicity of hepatitis B vaccine in term and preterm infants